Efficacy and Safety of Fixed Dose Combination GSP 301 Nasal Spray (NS) in the Treatment of Seasonal Allergic Rhinitis (SAR)
Public ClinicalTrials.gov record NCT02631551. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-Blind, Randomized, Parallel-Group, Comparative Study to Evaluate the Efficacy, Safety and Tolerability of a Fixed Dose Combination GSP 301 Nasal Spray (NS) Compared With Placebo Nasal Spray and Individual Monotherapy Formulations (Comparators) in Subjects (Aged 12 Years and Older) With Seasonal Allergic Rhinitis (SAR)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Study to evaluate the efficacy and safety of GSP 301 NS compared to placebo NS and to individual monotherapies (comparators) as well as the efficacy of these monotherapies (comparators) versus placebo NS over 14 days of study treatment
Study identification
- NCT ID
- NCT02631551
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,180 participants
Conditions and interventions
Conditions
Interventions
- GSP 301 NS Drug
- Olopatadine HCl NS Drug
- Mometasone furoate NS Drug
- GSP 301 Placebo NS Drug
Drug
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 2016 (Type not available)
- Primary completion
- Jul 2016 (Actual)
- Completion
- Jul 2016 (Actual)
- Last update posted
- Sep 25, 2018
2016
United States locations
- U.S. sites
- 37
- U.S. states
- 18
- U.S. cities
- 31
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigational Site 20 | Mission Viejo | California | — | — |
| Investigational Site 31 | San Diego | California | — | — |
| Investigational Site 29 | San Jose | California | — | — |
| Investigational Site 25 | Centennial | Colorado | — | — |
| Investigational Site 22 | Colorado Springs | Colorado | — | — |
| Investigational Site 10 | Jupiter | Florida | — | — |
| Investigational Site 30 | Miami | Florida | — | — |
| Investigational Site 37 | Marietta | Georgia | — | — |
| Investigational Site 15 | Stockbridge | Georgia | — | — |
| Investigational Site 23 | Stockbridge | Georgia | — | — |
| Investigational Site 11 | Louisville | Kentucky | — | — |
| Investigational Site 14 | Baltimore | Maryland | — | — |
| Investigational Site 33 | Wheaton | Maryland | — | — |
| Investigational Site 26 | Ypsilanti | Michigan | — | — |
| Investigational Site 19 | Minneapolis | Minnesota | — | — |
| Investigational Site 21 | St Louis | Missouri | — | — |
| Investigational Site 16 | Bellevue | Nebraska | — | — |
| Investigational Site 12 | Skillman | New Jersey | — | — |
| Investigational Site 36 | Rochester | New York | — | — |
| Investigational Site 18 | Raleigh | North Carolina | — | — |
| Investigational Site 27 | Cincinnati | Ohio | — | — |
| Investigational Site 34 | Middleburg Heights | Ohio | — | — |
| Investigational Site 32 | Medford | Oregon | — | — |
| Investigational Site 35 | Portland | Oregon | — | — |
| Investigational Site 13 | Orangeburg | South Carolina | — | — |
| Investigational Site 17 | Spartanburg | South Carolina | — | — |
| Investigational Site 3 | Austin | Texas | — | — |
| Investigational Site 5 | Austin | Texas | — | — |
| Investigational Site 8 | Austin | Texas | — | — |
| Investigational Site 1 | Kerrville | Texas | — | — |
| Investigational Site 7 | New Braunfels | Texas | — | — |
| Investigational Site 2 | San Antonio | Texas | — | — |
| Investigational Site 4 | San Antonio | Texas | — | — |
| Investigational Site 6 | San Antonio | Texas | — | — |
| Investigational Site 9 | San Antonio | Texas | — | — |
| Investigational Site 28 | Waco | Texas | — | — |
| Investigational Site 24 | Draper | Utah | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02631551, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 25, 2018 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02631551 live on ClinicalTrials.gov.